Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / India

Why Is Eisai In Vizag?

June 2010 | Industry Trend Analysis

Like other Japanese pharmaceutical companies, Eisai is conservative in nature and outlook. The Tokyo-based firm generates the majority of revenue in its domestic market and the US. Its exposure in Europe is limited and emerging markets are currently a low priority.

To read the full article, please choose one of the following options:

Subcribers please log in